“We have been advancing the industry with innovative preservation approaches for over two decades,” said David Plimpton, CEO and president. “This latest patent demonstrates our leadership in this category. Our broad portfolio of CHA offerings exemplifies our drive to bring effective alternative preservation mainstream.”
Caprylhydroxamic acid is a 100% natural and readily biodegradable chelating agent derived from coconut sourced caprylic acid. CHA is a biostatic ingredient that provides a strong hurdle to microbial growth across as wide pH range (ph-408). Robust broad spectrum protection against contamination by bacteria, yeast, and mold is achieved via combination of CHA with medium chain terminal diols, such as caprylyl glycol, glyceryl caprylate or caprylyl glyceryl ether.
The company offers its portfolio of CHA-diol broad spectrum system under the Spectrastat brand, with particular emphasis on 100% natural systems, such as Spectrastat G2 Natural MB (INCI: caprylhydroxamic acid (and) glyceryl caprylate (and) glycerin).
The patent recognizes the company’s ongoing commitment to innovation in the field of safe, effective and sustainable options for preservation of formulated products.
In October 2020, the Cosmetic Ingredient Review (CIR) released its final report on the safety of caprylhydroxamic acid as used in cosmetics, in which the independent Expert Panel for Cosmetic Ingredient Safety concluded that CHA is safe as used in the present practices of the industry. The conclusion further validated the outstanding track record of safety associated with CHA, said the company.
To date, the use of CHA has been reported in more than 5000 product SKUs around the world as documented by the Mintel Global New Products Database.